<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04285242</url>
  </required_header>
  <id_info>
    <org_study_id>MIPPaC</org_study_id>
    <nct_id>NCT04285242</nct_id>
  </id_info>
  <brief_title>Metabolic and Immunological Phenotyping in Patients With Cancer</brief_title>
  <acronym>MIPPaC</acronym>
  <official_title>Metabolic and Immunological Phenotyping in Patients With Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CCTU- Cancer Theme</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cambridge University Hospitals NHS Foundation Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      An observational study to investigate cachexia in participants with non-haematological
      cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A single-centre, non-randomised, observational study. This study will investigate the
      systemic metabolic and immunological changes that occur in cachexia. The aim is to better
      understand the mechanism(s) underlying weight loss in people with non-haematological cancer.
      This will help to facilitate future research to generate treatments to reverse weight loss
      and improve outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 2021</start_date>
  <completion_date type="Anticipated">November 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Serum cortisol level</measure>
    <time_frame>Change from baseline serum cortisol level at Day 2</time_frame>
    <description>Blood serum cortisol levels in weight losing and weight stable patients at baseline and Day 2</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Cancer</condition>
  <condition>Non-Hematologic Malignancy</condition>
  <arm_group>
    <arm_group_label>Participants with Cancer</arm_group_label>
    <description>Assessments and observations for up to 40 days with one overnight hospital stay.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Volunteers - Group A</arm_group_label>
    <description>Assessments and observations for up to 2 days with one overnight hospital stay.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Volunteers - Group B</arm_group_label>
    <description>Assessments and observations for up to 2 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observational assessments</intervention_name>
    <description>Clinical assessments</description>
    <arm_group_label>Healthy Volunteers - Group A</arm_group_label>
    <arm_group_label>Healthy Volunteers - Group B</arm_group_label>
    <arm_group_label>Participants with Cancer</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Male and Female participants who have cancer or are healthy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Have given written informed consent to participate

          -  Be aged 18 years or over at the time of signing the informed consent form

          -  Have a histological or cytological diagnosis of a non-haematological cancer

          -  Are willing and able to comply with study procedures and visits

        Exclusion Criteria:

          -  Active infection, as determined by the investigator based on clinical symptoms and /
             or fever and / or requirement for antibiotics

          -  Current treatment with chemotherapy, oral steroids or other immunosuppressive drugs
             (within 7 days of baseline investigations or during the study phase)

          -  Significant acute, chronic or psychiatric condition or laboratory abnormality which in
             the judgment of the investigator would place the patient at undue risk or interfere
             with the study.

          -  Intolerance to dairy products

          -  Women, who are pregnant, plan to become pregnant or are lactating
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claire Connell</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cambridge</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Early Phase Team Cambridge Cancer Trials Unit - Cancer Theme</last_name>
    <phone>01223216083</phone>
    <email>cctuep@addenbrookes.nhs.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cambridge Cancer Trials Centre, Coordination Team</last_name>
    <phone>01223216083</phone>
    <email>cctu.cancer@addenbrookes.nhs.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Addenbrooke's Hospital, Cambridge University Hospitals Foundation Trust,</name>
      <address>
        <city>Cambridge</city>
        <state>Cambridgeshire</state>
        <zip>CB2 0QQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cambridge University Hospitals NHS Foundation Trust</name>
      <address>
        <city>Cambridge</city>
        <state>England</state>
        <zip>CB2 2QQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>February 19, 2020</study_first_submitted>
  <study_first_submitted_qc>February 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 26, 2020</study_first_posted>
  <last_update_submitted>July 8, 2020</last_update_submitted>
  <last_update_submitted_qc>July 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Cambridge University Hospitals NHS Foundation Trust</investigator_affiliation>
    <investigator_full_name>CCTU- Cancer Theme</investigator_full_name>
    <investigator_title>Cambridge Clinical Trials Unit - Cancer Theme</investigator_title>
  </responsible_party>
  <keyword>Cancer</keyword>
  <keyword>Non-haematological</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

